Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 Study
Lisa Francesca Licitra, Makoto Tahara, Kevin Joseph Harrington, M. Olivera Hurtado de Mendoza, Yi Guo, Sercan Aksoy and 14 more
- Rank
- 16 of 2,889
- Percentile
- top 0.6%
- Where
- International Journal of Radiation Oncology*Biology*Physics, 2024
- Citations
- 34
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.